White, affluent, educated parents are least likely to choose HPV vaccination for their children: a cross-sectional study of the National Immunization Study - teen

Echo L Warner, Qian Ding, Lisa M Pappas, Kevin Henry, Deanna Kepka, Echo L Warner, Qian Ding, Lisa M Pappas, Kevin Henry, Deanna Kepka

Abstract

Background: Human Papillomavirus (HPV) vaccination coverage is below national goals in the United States. Research is needed to inform strategically designed interventions that target sociodemographic groups with underutilization of HPV vaccination.

Methods: Secondary data analysis of the National Immunization Survey-Teen 2013 measured association of sociodemographic factors (e.g., ethnicity/race, insurance) with HPV vaccination among females and males ages 13-17 (N = 18,959). Chi-square and multivariable Poisson regressions were conducted using survey-weighted statistics.

Results: Having a mother ≥35 years, a mother with some college, being of "Other" ethnicity/race, and having no providers who order vaccines from health departments was negatively associated with females initiating HPV vaccination. Having a mother with some college, being of Non-Hispanic White or "Other" ethnicity/race, and having some or no providers who order vaccines from health departments was negatively associated with males initiating HPV vaccination. These same factors were negatively associated with males completing HPV vaccination with the exception of "Other" ethnicity/race. In contrast, having an unmarried mother, being ages 15-17, having a hospital based provider, and receiving other adolescent vaccinations were positively associated with females initiating and completing HPV vaccination. Having an unmarried mother, health insurance that is not employer or union sponsored, and influenza and meningitis vaccinations was positively associated with male's initiating HPV vaccination. For males, being 15 or 17 years old and having other adolescent vaccinations was positively associated with vaccine completion. All findings p ≤ 0.05.

Conclusions: Future HPV vaccination interventions may benefit from targeting certain sociodemographic groups that were negatively associated with HPV vaccination in this study.

Keywords: Adolescent; Ethnicity; Gender; HPV; Males.

Conflict of interest statement

Ethics approval and consent to participate

Not applicable. Secondary analysis of publicly available data is considered exempt by the University of Utah Institutional Review Board.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

    1. Healthy People 2020 Topics & Objectives. 2014 05/23/2014]; Available from: .
    1. Human papillomavirus vaccination coverage among adolescent girls, 2007–2012, and postlicensure vaccine safety monitoring, 2006–2013 - United States. MMWR Morb Mortal Wkly Rep. 2013. 62(29): p. 591–5.
    1. Stokley S, et al. Compliance with recommendations and opportunities for vaccination at ages 11 to 12 years: evaluation of the 2009 national immunization survey-teen. Arch Pediatr Adolesc Med. 2011;165(9):813–818. doi: 10.1001/archpediatrics.2011.138.
    1. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007;45(2–3):107–114. doi: 10.1016/j.ypmed.2007.05.013.
    1. Holman DM, et al. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168(1):76–82. doi: 10.1001/jamapediatrics.2013.2752.
    1. Bednarczyk RA, et al. Health disparities in human papillomavirus vaccine coverage: trends analysis from the National Immunization Survey-Teen, 2008-2011. Clin Infect Dis. 2014;58(2):238–241. doi: 10.1093/cid/cit707.
    1. Kepka D, et al. Factors associated with early adoption of the HPV vaccine in US male adolescents include Hispanic ethnicity and receipt of other vaccines. Prev Med Rep. 2016;4:98–102. doi: 10.1016/j.pmedr.2016.05.014.
    1. Lai D, et al. Factors associated with increased HPV vaccine use in rural-frontier U.S. states. Public Health Nurs. 2016;33(4):283–294. doi: 10.1111/phn.12223.
    1. Reiter PL, et al. Early adoption of the human papillomavirus vaccine among Hispanic adolescent males in the United States. Cancer. 2014;120(20):3200–3207. doi: 10.1002/cncr.28871.
    1. Kepka D, et al. High school females and those with other vaccinations most likely to complete the human papillomavirus vaccine. Prev Med Rep. 2015;2:79–83. doi: 10.1016/j.pmedr.2014.12.008.
    1. Zimet GD. Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc Health. 2005;37(6 Suppl):S17–S23. doi: 10.1016/j.jadohealth.2005.09.010.
    1. Adjei Boakye E, et al. Approaching a decade since HPV vaccine licensure: racial and gender disparities in knowledge and awareness of HPV and HPV vaccine. Hum Vaccin Immunother. 2017:0.
    1. Reimer RA, et al. Ethnic and gender differences in HPV knowledge, awareness, and vaccine acceptability among white and Hispanic men and women. J Community Health. 2014;39(2):274–284. doi: 10.1007/s10900-013-9773-y.
    1. Zimet GD, Rosenthal SL. HPV vaccine and males: issues and challenges. Gynecol Oncol. 2010;117(2 Suppl):S26–S31. doi: 10.1016/j.ygyno.2010.01.028.
    1. Elam-Evans L, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — United States, 2013. MMWR Morb Mortal Wkly Rep. 2014;63(29):625–633.
    1. Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011. 60(50): p. 1705–1708.
    1. Markowitz, L., et al., Quadrivalent Human Papillomavirus Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2007. 56(RR02): p. 1–24.
    1. Jain N, et al. Determining accurate vaccination coverage rates for adolescents: the National Immunization Survey-Teen 2006. Public Health Rep. 2009;124(5):642–651. doi: 10.1177/003335490912400506.
    1. National Immunization Survey-Teen: A User's Guide for the 2013 Public-Use Data File. 2014, Centers for Disease Control and Prevention and National Center for Health Statistics.
    1. About the National Immunization Surveys. 2014 01/11/2015]; Available from: .
    1. The Social-Ecological Model: A Framework for Prevention. 2017 10/10/2017]; Available from: .
    1. Social Determinants of Health. 2017 10/10/2017]; Available from: .
    1. Dorell C, et al. Delay and refusal of human papillomavirus vaccine for girls, national immunization survey-teen, 2010. Clin Pediatr (Phila) 2014;53(3):261–269. doi: 10.1177/0009922813520070.
    1. Mohammed KA, et al. Factors associated with parents’ intent to vaccinate adolescents for human papillomavirus: findings from the 2014 National Immunization Survey–Teen. Prev Chronic Dis. 2017;14
    1. Immunization Education & Training: You Are the Key to HPV Cancer Prevention. 2016 10/10/2017]; Available from: .
    1. Ng J, et al. Human papillomavirus vaccination coverage among female adolescents in managed care plans — United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(42):1185–1189. doi: 10.15585/mmwr.mm6442a1.
    1. Foundation, K.F. The HPV Vaccine: Access and Use in the U.S. 2013 07/15/2013]; Available from: .
    1. Accelerating HPV. Vaccine uptake: urgency for action to prevent cancer. A report to the president of the United States from the President’s cancer panel. 2014. Bethesda: National Cancer Institute.
    1. Henry KA, et al. Geographic factors and human papillomavirus (HPV) vaccination initiation among adolescent girls in the United States. Cancer Epidemiol Biomark Prev. 2016;25(2):309–317. doi: 10.1158/1055-9965.EPI-15-0658.
    1. Henry KA, et al. Area-based socioeconomic factors and human papillomavirus (HPV) vaccination among teen boys in the United States. BMC Public Health. 2017;18(1):19. doi: 10.1186/s12889-017-4567-2.
    1. Human papillomavirus vaccines: WHO position paper, May 2017. Wkly Epidemiol Rec. 2017. 92(19): p. 241–68.
    1. Mishra GA, Pimple SA, Shastri SS. HPV vaccine: one, two, or three doses for cervical cancer prevention? Indian J Med Paediatr Oncol. 2015;36(4):201–206. doi: 10.4103/0971-5851.171534.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner